Hear From Top Industry Thought Leaders as They Showcase Challenges and Solutions Impacting the Pharmaceutical Industry
The 2025 ISPE Biotechnology Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on the evolving landscape and future of the development and manufacturing of biotechnology products.
This conference will focus on unique challenges associated with innovative pharmaceutical products applied and transferred to the (new) biosimilar, bio better, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based product development and new applications. In addition, the conference will feature presentations with a focus on enablers for process intensification, speed-to-market, sustainability, product technology transfer, analytics and quality management, operational readiness, digital transformation, and manufacturing.
Featured Speakers
SVP Head of Global Quality Compliance & Systems
Takeda - Boston
Head of Institute Surveillance
Austrian Agency for Health and Food Safety (AGES)
Vice President, Operations Commercialization
Amgen
Group Vice President, API & Dry Products Manufacturing
Eli Lilly and Company
Vice President – Head of CMC Regulatory Affairs
Gilead Sciences
Unlock your potential with Continuing Education!
Invest in your future! Join us at the 2025 ISPE Biotechnology Conference to enhance your skills, share ideas, connect with peers, and earn 1.2 CEUs. Start your journey towards lifelong learning and career advancement today!
Your Conference Experience

Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.

Networking
Networking
Connect with top industry experts and expand your professional network at our exclusive networking sessions.

Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.

On-Demand Content
On-Demand Content
Access exclusive conference content anytime with our on-demand library for 90 days.
5
+
Networking Hours
19
+
Education Hours
50
+
Exhibitors
60
+
Speakers
Conference Highlights

Where Are We on the Digital Road Map? Find Out at the 2025 ISPE Biotechnology Conference
Digital transformation isn’t a future concept in the biopharmaceutical industry—it is already impacting manufacturing and quality control processes. Recent advancements and best practices will be showcased at the upcoming 2025 ISPE Biotechnology Conference, where the track “Implementing Digital Initiatives in the Biopharmaceutical Industry: Where Are We on the Road Map?” dives deep into the real-world progress, challenges, and wins from across the industry.

Process Intensification, Continuous Manufacturing, and Sustainability
Biotech companies are meeting modern sustainability objectives and gaining a competitive advantage by implementing process intensification strategies and continuous manufacturing technologies to improve production efficiency while reducing impacts on our environment. Attendees will learn about innovative approaches to process intensification, continuous manufacturing, and sustainability in this featured track at the 2025 ISPE Biotechnology Conference.

Trends and Opportunities: How Artificial Intelligence (AI) and Machine Learning (ML) are Reshaping Biotechnology
As biotechnology continues to advance at an extraordinary pace, organizations face a common challenge: how to keep up with increasing complexity while accelerating speed to market. From biosimilars and bio-betters to cell and gene therapies, advanced therapy medicinal products (ATMPs), and mRNA-based treatments, the industry is transforming, and so too must the tools the industry uses to develop and manufacture these innovative therapies.
Testimonials
International Program Committee
Chair
Global Head of Group Smart Manufacturing
Merck KGaA Darmstadt, Germany
North American Liaison
Associate Director, Small and Large Scale Molecules; Professor of Practice, IIT
Moderna
Board Liaison
Founder
Robur Life Science Advisory AB
Women in Pharma® Liaison
Director
Merck & Co Inc
Chapter Liaison
Director, Product Operations Strategy and Business Lead
Takeda
Director, Life Sciences
Barry-Wehmiller Design Group
Senior Director, Quality Compliance BioNTainer
BioNTech US Inc.
Compliance Head for Vaccines
Sanofi
Regulatory Advisor
ISPE
Data Engineer - Global MSAT Process Analytics
Thermo Fisher Scientific Brisbane, Australia
Technology Manager Biotechnology
CRB Group GmbH
Scientist & Software Architect
Fraunhofer IESE
US Director, New Process Technology
Arcadis US
Senior Scientific Advisor
Körber Pharma Austria
Senior Process Engineer
WuXi Biologics (Shanghai) Co., Ltd.
Emerging Leader
Manufacturing Associate 2, Cell and Gene Therapy
ElevateBio
Emerging Leader
Senior Project Engineer
Barry-Wehmiller Design Group
Emerging Leader
Quality Control Inspector
MilliporeSigma
Emerging Leader
Senior Engineer
Moderna Therapeutics
Emerging Leader
Principal Engineer
Vertex
Emerging Leader
Senior Quality Assurance Specialist
Sanofi